Full-Time

Senior Warehouse Systems and Planning Manager

Posted on 11/23/2025

Cencora

Cencora

10,001+ employees

Global pharmaceutical distribution and services provider

No salary listed

Birmingham, UK

In Person

Some UK travel required with overnight stays; onsite role.

Category
Operations & Logistics (1)
Requirements
  • Strong knowledge of warehouse management systems (WMS) and automated technologies.
  • Proven experience in warehouse operations management, with a minimum of 3-5 years in a leadership role managing managers as direct reports, with at least 2 years in an automated warehouse environment.
  • Excellent leadership, communication and problem-solving skills to lead, motivate and develop teams in large, in a fast-paced, complex 24/7 operation (including managers).
  • Excellent organisational and multitasking abilities and the ability to manage within a set budget.
  • Proficiency in data analysis and performance metrics including KPIs.
  • Strong problem-solving skills and high attention to detail.
  • Ability to build strong and effective relationships across departments, demonstrating a collaborative approach.
  • Strong communication and interpersonal skills.
  • In-depth understanding of global trends, agendas, ESG frameworks, standards, and regulatory environments.
  • Proven track record in managing audit trails and carrying out the appropriate ESG procedures to ensure compliance according to the GDP guidelines.
Responsibilities
  • Lead the Control Room function, ensuring the warehouse management systems (Knapp/Manhattan) effectively utilise workload information daily to optimise service and efficiency.
  • Lead the CI function to improve system performance and Operational processes to enhance productivity, to ensure we meet our customers’ requirements.
  • Lead, develop and manage a team of specialists ensuring high performance and continuous improvement in planning and establish KPIs and metrics to the warehouse leadership and operations teams to support their planning and tactical processes.
  • Oversee the Labour management function and provide reports and analysis to the senior leadership regarding performance.
  • Develop and implement strategic plans to align planning with CLC and broader organisational objectives.
  • Promote and enforce a safe working environment, ensuring compliance with health and safety regulations.
  • Working with people leaders to develop a culture of continuous improvement across the centrallogistics centre and making recommendations to the Head of CLC.
  • Optimise resource allocation, including recruitment, equipment and materials to meet operational demands efficiently.
  • Lead, motivate and inspire a multi-functional team of specialists, be a role model throughdemonstrating the Guiding Principles in the everydayand continuously work towards the Cencora Purpose.
  • Foster a positive and collaborative work environment, encouraging teamwork and continuous improvement.Embracing a learning and development culture across within the function liaising with L&D team to maximise output.
  • Support teams to achieve business participation levels in employment engagement surveys to utilise the results to enable the site action plans.
  • Champion and lead DE&I, embracing an open dialogue and collaboration as part of the sites culture, which empowers everyone to share their unique perspectives and feel valued, respected, and supported for it.
  • Recruit, train and develop all direct reports, maintainingappropriate liaison with Human Resources department.
  • Collaborate closely and maintain strong relationships with supply chain teams to ensure the ad-hoc and longer-term planning of promotional and project supply chain activities.
  • Drive cross functional collaboration with IT/Knapp/Manhattan teams to address operational challenges and implement solutions.
  • Champion and lead the health and safety culture which ensures safe processes, procedures and behaviours as well as continuous improvement through best practice activities.
  • Provide effective leadership and motivation through regular team briefings
  • Monitor key performance indicators (KPIs) and operational metrics to drive performance against service, compliance, productivity and cost in line with targets and where relevant ensure the implementation of actions to reverse identified areas of under-performance.
  • Identify opportunities for process improvements and implement best practices.
  • Be responsible for the correct headcount to maintain both service and productivity measures in operations according to all relevant KPIs.
  • Develop and manage the warehouse and overhead budgets.
  • Monitor expenses and ensure cost-effective operations.
  • Identify and implement cost-saving initiatives.
  • Coordinate the relationship and workload of the external on-site systems team (Knapp), delivering on day-to-day systems monitoring, fault resolution, ticket system helpdesk, and continuous improvement changes.
  • Oversee the change control budget for system enhancements and improvements.
  • Develop and implement risk management strategies to mitigate operational disruptions ensuring timely resolution of system issues and implementation of system updates and improvements.
  • Lead response efforts for operational crises and ensure continuity of service, liaising with senior stakeholders.
  • Liaise with supported sites to resolve any supply issues and create future plans to improve the customer experience.
  • Provide ongoing training and development opportunities for team members to enhance their skills and knowledge.
  • Ensure succession plans are in place that support the CLC and the UK business to ensure there are no gaps in structure.
  • Conduct the performance management process for direct reports, ensuring regular two-way communication.
  • Adherence to business and team objectives and consistency; challenging positively as appropriate.
  • Maintain high standards of quality and accuracy in all warehouse operations, ensuring compliance with relevant regulatory requirements and company policies.
  • Maintain and enhance strong relationships across multiple internal stakeholders to ensure seamless collaboration and communication that all systems, processes and procedures in place are robust, efficient and fit for purpose.
  • Conduct regular audits and inspections for system applications to maintain compliance and address any deficiencies.
  • Monitor and improve systems and planning processes through WMS, to enhance delivery performance and reduce costs.
  • Prepare and present reports on planning and performance to senior stakeholders.
  • Facilitate forums that focus on long term strategies for improvement to the site.
  • Champion and lead the Health and Safety culture which ensures safe processes, procedures and behaviours as well as continuous improvement through best practice activities in accordance with the SOP’s.
  • Working with the H&S Manager conduct regular safety audits and risk assessments.
  • Commit to advancing our ESG initiatives to create healthier futures around the world.
  • Ensure a culture of being safe, legal and compliant.
Desired Qualifications
  • Previous experience working with Knapp and/or Manhattan.
  • Experience in the pharmaceutical industry.
  • Knowledge of regulatory compliance and quality standards in pharmaceutical distribution

Cencora provides global pharmaceutical distribution and a range of services, including specialty pharmacy, consulting, supply-chain management, patient support programs, and data analytics for healthcare providers, manufacturers, and veterinary practices. It works by combining physical drug distribution with value-added services such as inventory management, regulatory compliance guidance, patient support, and data-driven insights to optimize supply chains and outcomes. The company differentiates itself with an integrated, end-to-end offering that spans distribution, clinical services, analytics, and advisory support to help clients run more efficient operations and lower costs. Its goal is to improve healthcare outcomes by delivering comprehensive pharmaceutical solutions that enable better care and lower overall expenses.

Company Size

10,001+

Company Stage

IPO

Headquarters

Pennsylvania

Founded

1907

Simplify Jobs

Simplify's Take

What believers are saying

  • OneOncology $5B acquisition completed December 2025 boosts specialty oncology leadership.
  • EyeSouth retina business $1.1B deal expands Retina Consultants, accretive to EPS post-closure.
  • FY2026 EPS guidance raised to $17.65–$17.90 despite revenue headwinds from biosimilars.

What critics are saying

  • Frank R. Cruz investigation triggers shareholder lawsuits after May 6, 2026 Q2 revenue miss.
  • McKesson and Cardinal Health seize specialty drug share via aggressive GLP-1 pricing.
  • Inflation Reduction Act price cuts compress margins beyond $2B Q2 2026 headwind.

What makes Cencora unique

  • Cencora rebranded from AmerisourceBergen in August 2023, trading as COR on NYSE.
  • Cencora operates 1,400 locations across 50+ countries for global pharmaceutical distribution.
  • Cencora uniquely serves human and animal health with specialty pharmacy and MSO platforms.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 23rd, 2026
Cencora buys EyeSouth Partners' retina business for $1.1B to expand Retina Consultants of America

Cencora has signed a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. The affiliated retina physicians will join Cencora's Retina Consultants of America, a leading management services organisation. The pharmaceutical solutions company expects the acquisition to be slightly accretive to its adjusted diluted earnings per share in the first twelve months following closure, net of financing costs. The transaction requires regulatory approvals and customary closing conditions. Cencora's reaffirmed fiscal 2026 financial guidance does not currently include the transaction closing within that fiscal year. BofA Securities served as lead financial advisor to Cencora, whilst Jefferies advised EyeSouth Partners, a portfolio company of Olympus Partners.

The Associated Press
Mar 17th, 2026
Cencora CFO James Cleary to retire after eight years, search underway for successor

Cencora has announced that Chief Financial Officer James F. Cleary will retire effective 30 June 2026. The pharmaceutical solutions company has engaged an executive search firm to identify potential successors from internal and external candidates. Cleary, 62, has served as CFO since November 2018 and joined Cencora in February 2015 following its acquisition of MWI Veterinary Supply, where he had been chief executive officer for over a decade. He will serve in an advisory capacity through the end of 2026 to ensure a smooth transition. Cencora reaffirmed its previously issued adjusted diluted earnings per share guidance range of $17.45 to $17.75 for fiscal year 2026. The company, ranked number 10 on the Fortune 500, generates more than $300 billion in annual revenue.

TradingView
Feb 11th, 2026
Cencora prices $3B senior notes offering across multiple maturities

Cencora has priced a $3 billion senior notes offering across various maturities, the company announced on 10 February 2026. No further details about the specific maturities, interest rates or intended use of proceeds were disclosed in the announcement.

Yahoo Finance
Feb 4th, 2026
Cencora raises fiscal 2026 guidance after completing OneOncology acquisition

Cencora reported 12% adjusted operating income growth and 9% adjusted diluted EPS growth in its fiscal 2026 first quarter, driven by its US healthcare solutions business. The company raised its full-year guidance to reflect year-over-year adjusted operating income growth of 11.5% to 13.5%. CEO Robert Mauch announced the completion of Cencora's acquisition of the majority remaining equity interest in OneOncology. The deal strengthens Cencora's specialty pharmaceutical leadership and MSO (management services organisation) platform. Cencora's strategy focuses on three priorities: strengthening leadership in specialty pharmaceuticals, partnering with market leaders, and enhancing patient access to pharmaceuticals. The company is leveraging technology and advanced analytics to improve customer experience and operational excellence whilst expanding its pharmaceutical-centric MSO footprint.

Yahoo Finance
Feb 4th, 2026
Cencora beats profit estimates on specialty drug demand, completes $5B OneOncology acquisition

Cencora beat Wall Street's first-quarter profit estimates on Wednesday, driven by sustained demand for specialty medicines and GLP-1 therapies. The drug distributor reported adjusted earnings of $4.08 per share, exceeding analysts' expectations of $4.04. The company completed its $5 billion acquisition of OneOncology from TPG in December, strengthening its presence in cancer care. It raised its fiscal 2026 adjusted operating income growth forecast to 11.5% to 13.5%, up from 8% to 10% previously. However, quarterly revenue of $85.93 billion fell short of expectations of $86.03 billion, sending shares down 5% in pre-market trading. Sales at its largest unit, US healthcare solutions, rose 5% year-over-year to $76.2 billion, boosted by prescription volumes of weight-loss drugs and specialty medicines.

INACTIVE